Comparison of effects of socioeconomic and geographic variations on survival for adults and children with glioma

Journal of Neurosurgery

Volumn 105 PEDIATRICS, Issue SUPPL. 4, 2006, Pages 297-305

  Tseng, Ming Yuan ^a   Tseng, Jen Ho ^b   Merchant, Edwin ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Brain neoplasm; Geographic region; Glioma; Pediatric neurosurgery; Socioeconomic status; Survival analysis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHI SQUARE TEST; CHILD; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENDER; GEOGRAPHICAL VARIATION (SPECIES); GLIOMA; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MORTALITY; MULTIVARIATE ANALYSIS; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SOCIOECONOMICS; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

EID: 33845695464     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/ped.2006.105.4.297     Document Type: Article

References (41)

1. Bloom HJ, Glees J, Bell J, Ashley SE, Gorman C: The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981. Int J Radiat Oncol Biol Phys 18:723-745, 1990
2. Brunner E, Shipley MJ, Blane D, Smith GD, Marmot MG: When does cardiovascular risk start? Past and present socioeconomic circumstances and risk factors in adulthood. J Epidemiol Community Health 53:757-764, 1999
3. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59:1617-1625, 1987
4. Carstairs V, Morris R: Deprivation and mortality: an alternative to social class? Community Med 11:210-219, 1989
5. Chandler KL, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32:716-720, 1993
6. Coleman MP, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, et al: Cancer Survival Trends in England and Wales, 1971-1995: Deprivation and NHS Region. London: The Stationary Office, 1999
7. Coleman MP, Babb P, Mayer D, Quinn MJ, Sloggett A: Cancer Survival Trends in England and Wales, 1971-1995: Deprivation and NHS Region (CD-ROM). London: Office for National Statistics, 1999
8. Coleman MP, Babb P, Sloggett A, Quinn M, De Stavola B: Socioeconomic inequalities in cancer survival in England and Wales. Cancer 91 (1 Suppl):208-216, 2001
9. Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M, The Comparative Risk Assessment collaborating group (Cancers): Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366:1784-1793, 2005
10. Davis FG, Freels S, Grutsch J, Barlas S, Brem S: Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 88:1-10, 1998
11. Dickinson HO, Salotti JA, Birch PJ, Reid MM, Malcolm A, Parker L: How complete and accurate are cancer registrations notified by the National Health Service Central Register for England and Wales? J Epidemiol Community Health 55:414-422, 2001
12. Dickman PW, Auvinen A, Voutilainen ET, Hakulinen T: Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study. J Epidemiol Community Health 52:727-734, 1998
13. Dinnes J, Cave C, Huang S, Major K, Milne R: The effectiveness and cost-effectiveness of temozolamide for the treatment of recurrent malignant glioma: a rapid and systematic review. Health Technol Assess 5:1-73, 2001
14. Duff SE, Wood C, McCredie V, Levine E, Saunders MP, O'Dwyer ST: Waiting times for treatment of rectal cancer in North West England. J R Soc Med 97:117-118, 2004
15. Evans BT, Pritchard C: Cancer survival rates and GDP expenditure on health: a comparison of England and Wales and the USA, Denmark, Netherlands, Finland, France, Germany, Italy, Spain and Switzerland in the 1990s. Public Health 114:336-339, 2000
16. Foreman NK, Love S, Thorne R: Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr Neurosurg 24:119-125, 1996
17. Galobardes B, Costanza MC, Bernstein MS, Delhumeau C, Morabia A: Trends in risk factors for lifestyle-related diseases by socioeconomic position in Geneva, Switzerland, 1993-2000: health inequalities persist. Am J Public Health 93:1302-1309, 2003
18. Johannesen TB, Langmark F, Lote K: Cause of death and longterm survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer 39:2355-2363, 2003
19. Kallio M, Sankila R, Jääskeläinen J, Karjalainen S, Hakulinen T: A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer 68:1394-1400, 1991
20. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K: Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 74:27-37, 1991
21. Kleihues P, Cavenee WK (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press, 2000
22. Lashford LS, Thiesse P, Jouvet A, Jaspan T, Couanet D, Griffiths PD, et al: Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup study. J Clin Oncol 20:4684-4691, 2002
23. Law MR, Morris JK: Why is mortality higher in poorer areas and in more northern areas of England and Wales? J Epidemiol Community Health 52:344-352, 1998
24. Maheswaran R, Strachan DP, Dodgeon B, Best NG: A population-based case-control study for examining early life influences on geographical variation in adult mortality in England and Wales using stomach cancer and stroke as examples. Int J Epidemiol 31:375-382, 2002
25. O'Hanlon S, Forster DP, Lowry RJ: Oral cancer in the North-East of England: incidence, mortality trends and the link with material deprivation. Community Dent Oral Epidemiol 25:371-376, 1997
26. Paterson ICM, John G, Adams Jones D: Effect of deprivation on survival of patients with head and neck cancer: a study of 20,131 cases. Clin Oncol (R Coll Radiol) 14:455-458, 2002
27. Pell JP, Pell ACH, Norrie J, Ford I, Cobbe SM: Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. BMJ 320:15-19, 2000
28. Power C, Graham H, Due P, Hallqvist J, Joung I, Kuh D, et al: The contribution of childhood and adult socioeconomic position to adult obesity and smoking behaviour: an international comparison. Int J Epidemiol 34:335-344, 2005
29. Quinn M, Babb P, Brock A, Kirby L, Jones J: Cancer trends in England and Wales 1950-1999. Studies on Medical and Population Subjects No. 66. London: The Stationery Office, 2001
30. Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, et al: Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352:978-986, 2005
31. Sgouros S, Fineron PW, Hockley AD: Cerebellar astrocytoma of childhood: long-term follow-up. Childs Nerv Syst 11:89-96, 1995
32. Stiller CA, Bunch KJ: Brain and spinal tumours in children aged under two years: incidence and survival in Britain, 1971-85. Br J Cancer 66 (Suppl 18):S50-S53, 1992
33. Sundquist J, Bajekal M, Jarman B, Johansson SE: Underprivileged area score, ethnicity, social factors and general mortality in district health authorities in England and Wales. Scand J Prim Health Care 14:79-85, 1996
34. Uff CEG, Lawson DDA, Giles G, Bavetta S: The two-week waiting time standard for cancer: a neurosurgical perspective. Br J Neurosurg 19:334-337, 2005
35. van de Mheen H, Stronks K, Looman CW, Mackenbach JP: Does childhood socioeconomic status influence adult health through behavioural factors? Int J Epidemiol 27:431-437, 1998
36. Wasserfallen JB, Ostermann S, Pica A, Mirimanoff RO, Leyvraz S, Villemure JG, et al: Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death. Cancer 101:2098-2105, 2004
37. West CGH, Gattamaneni R, Blair V: Radiotherapy in the treatment of low-grade astrocytomas. I. A survival analysis. Childs Nerv Syst 11:438-442, 1995
38. Whittle IR, Basu N, Grant R, Walker M, Gregor A: Management of patients aged . 60 years with malignant glioma: good clinical status and radiotherapy determine outcome. Br J Neurosurg 16:343-347, 2002
39. Williams B, Whatmough P, McGill J, Rushton L: Impact of private funding on access to elective hospital treatment in the regions of England and Wales. National records survey. Eur J Public Health 11:402-406, 2001
40. Woods LM, Rachet B, Riga M, Stone N, Shah A, Coleman MP: Geographical variation in life expectancy at birth in England and Wales is largely explained by deprivation. J Epidemiol Community Health 59:115-120, 2005
41. Wrigley H, Roderick P, George S, Smith J, Mullee M, Goddard J: Inequalities in survival from colorectal cancer: a comparison of the impact of deprivation, treatment, and host factors on observed and cause specific survival. J Epidemiol Community Health 57:301-309, 2003